A-1 Acid Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 12, 2025, 12:02 am

Market Cap	568 Cr.
Current Price	494
High / Low	535/290
Stock P/E	160
Book Value	41.6
Dividend Yield	0.30 %
ROCE	4.67 %
ROE	2.75 %
Face Value	10.0
PEG Ratio	29.36

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for A-1 Acid Ltd

Competitors of A-1 Acid Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Fischer Medical Ventures Ltd	5,222 Cr.	819	919/454	2,331	15.2	0.00 %	5.25 %	4.55 %	10.0
Emmessar Biotech & Nutrition Ltd	16.0 Cr.	31.9	64.0/27.2	21.0	15.6	0.00 %	11.4 %	10.6 %	10.0
Cochin Minerals & Rutile Ltd	204 Cr.	261	415/238	18.4	198	3.07 %	26.6 %	5.82 %	10.0
Archean Chemical Industries Ltd	7,419 Cr.	601	832/408	33.9	143	0.50 %	25.8 %	19.4 %	2.00
Alufluoride Ltd	358 Cr.	457	581/341	16.1	122	0.66 %	25.1 %	22.2 %	10.0
Industry Average	5,479.13 Cr	520.76		253.09	146.20	0.51%	15.23%	10.70%	7.82

All Competitor Stocks of A-1 Acid Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	84.79	113.44	93.84	86.11	79.03	71.62	58.97	47.20	41.76	60.43	70.14	77.76	76.36
Expenses	81.36	111.14	91.32	85.10	77.95	71.99	59.18	47.31	40.59	60.26	69.39	75.26	73.56
Operating Profit	3.43	2.30	2.52	1.01	1.08	-0.37	-0.21	-0.11	1.17	0.17	0.75	2.50	2.80
OPM %	4.05%	2.03%	2.69%	1.17%	1.37%	-0.52%	-0.36%	-0.23%	2.80%	0.28%	1.07%	3.22%	3.67%
Other Income	1.36	2.21	2.18	0.41	0.80	2.96	1.61	1.15	0.39	1.88	1.52	0.07	0.14
Interest	0.31	0.34	0.47	0.35	0.54	0.47	0.22	0.15	0.13	0.25	0.27	0.34	0.68
Depreciation	0.81	0.84	1.05	0.96	1.03	0.96	0.89	0.90	0.90	0.90	0.88	0.89	0.90
Profit before tax	3.67	3.33	3.18	0.11	0.31	1.16	0.29	-0.01	0.53	0.90	1.12	1.34	1.36
Tax %	28.61%	25.83%	26.42%	90.91%	41.94%	6.90%	37.93%	300.00%	60.38%	17.78%	25.00%	27.61%	26.47%
Net Profit	2.61	2.48	2.34	0.02	0.19	1.07	0.18	-0.04	0.21	0.75	0.84	0.97	1.00
EPS in Rs	2.27	2.16	2.03	0.02	0.17	0.93	0.16	-0.03	0.18	0.65	0.73	0.84	0.87

Last Updated: February 28, 2025, 4:03 pm

Below is a detailed analysis of the quarterly data for A-1 Acid Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 76.36 Cr.. The value appears to be declining and may need further review. It has decreased from 77.76 Cr. (Sep 2024) to 76.36 Cr., marking a decrease of 1.40 Cr..
For Expenses, as of Dec 2024, the value is 73.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 75.26 Cr. (Sep 2024) to 73.56 Cr., marking a decrease of 1.70 Cr..
For Operating Profit, as of Dec 2024, the value is 2.80 Cr.. The value appears strong and on an upward trend. It has increased from 2.50 Cr. (Sep 2024) to 2.80 Cr., marking an increase of 0.30 Cr..
For OPM %, as of Dec 2024, the value is 3.67%. The value appears strong and on an upward trend. It has increased from 3.22% (Sep 2024) to 3.67%, marking an increase of 0.45%.
For Other Income, as of Dec 2024, the value is 0.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Sep 2024) to 0.14 Cr., marking an increase of 0.07 Cr..
For Interest, as of Dec 2024, the value is 0.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.34 Cr. (Sep 2024) to 0.68 Cr., marking an increase of 0.34 Cr..
For Depreciation, as of Dec 2024, the value is 0.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.89 Cr. (Sep 2024) to 0.90 Cr., marking an increase of 0.01 Cr..
For Profit before tax, as of Dec 2024, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from 1.34 Cr. (Sep 2024) to 1.36 Cr., marking an increase of 0.02 Cr..
For Tax %, as of Dec 2024, the value is 26.47%. The value appears to be improving (decreasing) as expected. It has decreased from 27.61% (Sep 2024) to 26.47%, marking a decrease of 1.14%.
For Net Profit, as of Dec 2024, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.97 Cr. (Sep 2024) to 1.00 Cr., marking an increase of 0.03 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.84 (Sep 2024) to 0.87, marking an increase of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:19 pm

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	97	85	106	100	141	116	145	310	331	206	285
Expenses	93	82	99	104	143	112	141	301	326	206	278
Operating Profit	3	3	7	-4	-2	4	4	9	4	0	6
OPM %	4%	4%	6%	-4%	-2%	3%	3%	3%	1%	0%	2%
Other Income	0	0	0	11	9	4	4	4	6	6	4
Interest	2	1	1	2	1	1	1	1	2	1	2
Depreciation	2	1	1	2	0	3	3	3	4	4	4
Profit before tax	0	1	4	4	6	4	4	8	5	2	5
Tax %	25%	26%	33%	49%	25%	24%	34%	26%	24%	36%
Net Profit	0	1	3	2	4	3	3	6	4	1	4
EPS in Rs	1.08	7.67	25.00	2.37	3.63	2.77	2.37	5.49	3.14	0.96	3.09
Dividend Payout %	0%	16%	0%	0%	0%	0%	0%	27%	48%	157%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	200.00%	-33.33%	100.00%	-25.00%	0.00%	100.00%	-33.33%	-75.00%
Change in YoY Net Profit Growth (%)	0.00%	-233.33%	133.33%	-125.00%	25.00%	100.00%	-133.33%	-41.67%

A-1 Acid Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	8%
3 Years:	12%
TTM:	30%

Compounded Profit Growth
10 Years:	%
5 Years:	-21%
3 Years:	-21%
TTM:	151%

Stock Price CAGR
10 Years:	%
5 Years:	60%
3 Years:	24%
1 Year:	38%

Return on Equity
10 Years:	%
5 Years:	8%
3 Years:	8%
Last Year:	3%

Last Updated: Unknown

Balance Sheet

Last Updated: January 13, 2025, 2:29 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	1	1	1	7	10	10	10	12	12	12	12
Reserves	7	7	10	7	25	27	30	35	37	36	36
Borrowings	13	12	19	16	15	6	17	26	14	11	22
Other Liabilities	3	6	8	8	4	4	4	7	5	5	5
Total Liabilities	24	26	38	39	53	48	61	80	68	64	75
Fixed Assets	4	3	11	9	14	11	14	17	16	13	12
CWIP	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	2	3	5	5
Other Assets	20	23	26	30	38	37	47	60	48	45	58
Total Assets	24	26	38	39	53	48	61	80	68	64	75

Below is a detailed analysis of the balance sheet data for A-1 Acid Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
For Reserves, as of Sep 2024, the value is ₹36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 36.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹22.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 11.00 Cr. (Mar 2024) to ₹22.00 Cr., marking an increase of 11.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹75.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2024) to ₹75.00 Cr., marking an increase of 11.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to ₹12.00 Cr., marking a decrease of 1.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Sep 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹58.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to ₹58.00 Cr., marking an increase of 13.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹75.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2024) to ₹75.00 Cr., marking an increase of 11.00 Cr..

Notably, the Reserves (36.00 Cr.) exceed the Borrowings (22.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	3	-6	8	-4	-0	19	11
Cash from Investing Activity +	0	-7	-0	-6	-9	-4	-3
Cash from Financing Activity +	-4	14	-7	9	9	-15	-6
Net Cash Flow	-1	0	0	-0	-0	-0	2

Free Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-10.00	-9.00	-12.00	-20.00	-17.00	-2.00	-13.00	-17.00	-10.00	-11.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	69	87	76	89	70	78	91	54	42	55
Inventory Days	3	7	2	4	2	4	6	3	2	4
Days Payable	3	8	5	14	4	1	4	4	1	6
Cash Conversion Cycle	70	86	73	80	68	81	93	54	43	53
Working Capital Days	61	68	55	70	79	86	101	57	42	56
ROCE %		13%	23%	18%	17%	11%	9%	15%	10%	5%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	70.00%	70.00%	70.00%	70.00%	70.03%	70.03%	70.03%	70.03%	70.03%	70.03%	70.03%	70.03%
FIIs	0.00%	0.00%	0.00%	2.85%	2.85%	2.85%	2.85%	2.90%	2.90%	2.90%	2.90%	2.90%
Public	30.00%	30.00%	30.00%	27.14%	27.12%	27.11%	27.11%	27.06%	27.07%	27.08%	27.07%	27.07%
No. of Shareholders	315	327	980	1,339	1,961	2,106	2,085	2,071	2,028	1,845	1,897	1,750

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.95	3.14	5.48	2.37
Diluted EPS (Rs.)	0.95	3.14	5.48	2.37
Cash EPS (Rs.)	4.41	6.67	8.52	5.54
Book Value[Excl.RevalReserv]/Share (Rs.)	41.54	42.09	40.45	40.21
Book Value[Incl.RevalReserv]/Share (Rs.)	41.54	42.09	40.45	40.21
Revenue From Operations / Share (Rs.)	179.25	287.48	269.88	145.18
PBDIT / Share (Rs.)	5.60	9.27	11.46	7.68
PBIT / Share (Rs.)	2.48	5.79	8.55	4.88
PBT / Share (Rs.)	1.82	4.19	7.50	4.15
Net Profit / Share (Rs.)	1.28	3.19	5.61	2.73
NP After MI And SOA / Share (Rs.)	0.95	3.14	5.48	2.73
PBDIT Margin (%)	3.12	3.22	4.24	5.29
PBIT Margin (%)	1.38	2.01	3.16	3.35
PBT Margin (%)	1.01	1.45	2.78	2.86
Net Profit Margin (%)	0.71	1.11	2.07	1.88
NP After MI And SOA Margin (%)	0.53	1.09	2.03	1.88
Return on Networth / Equity (%)	2.29	7.46	13.55	6.79
Return on Capital Employeed (%)	5.57	12.45	18.76	10.97
Return On Assets (%)	1.72	5.33	7.91	4.47
Long Term Debt / Equity (X)	0.05	0.09	0.11	0.09
Total Debt / Equity (X)	0.22	0.29	0.55	0.41
Asset Turnover Ratio (%)	3.14	4.48	4.41	0.00
Current Ratio (X)	3.48	3.20	2.03	2.67
Quick Ratio (X)	3.33	3.11	1.94	2.56
Interest Coverage Ratio (X)	8.50	5.81	10.93	10.66
Interest Coverage Ratio (Post Tax) (X)	2.94	3.00	6.35	4.79
Enterprise Value (Cr.)	399.87	401.40	325.92	115.99
EV / Net Operating Revenue (X)	1.94	1.21	1.05	0.79
EV / EBITDA (X)	62.10	37.67	24.72	15.10
MarketCap / Net Operating Revenue (X)	1.92	1.18	0.96	0.68
Price / BV (X)	8.29	8.07	6.45	2.48
Price / Net Operating Revenue (X)	1.92	1.18	0.96	0.68
EarningsYield	0.00	0.01	0.02	0.02

After reviewing the key financial ratios for A-1 Acid Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
For Cash EPS (Rs.), as of Mar 24, the value is 4.41. This value is within the healthy range. It has decreased from 6.67 (Mar 23) to 4.41, marking a decrease of 2.26.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 41.54. It has decreased from 42.09 (Mar 23) to 41.54, marking a decrease of 0.55.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 179.25. It has decreased from 287.48 (Mar 23) to 179.25, marking a decrease of 108.23.
For PBDIT / Share (Rs.), as of Mar 24, the value is 5.60. This value is within the healthy range. It has decreased from 9.27 (Mar 23) to 5.60, marking a decrease of 3.67.
For PBIT / Share (Rs.), as of Mar 24, the value is 2.48. This value is within the healthy range. It has decreased from 5.79 (Mar 23) to 2.48, marking a decrease of 3.31.
For PBT / Share (Rs.), as of Mar 24, the value is 1.82. This value is within the healthy range. It has decreased from 4.19 (Mar 23) to 1.82, marking a decrease of 2.37.
For Net Profit / Share (Rs.), as of Mar 24, the value is 1.28. This value is below the healthy minimum of 2. It has decreased from 3.19 (Mar 23) to 1.28, marking a decrease of 1.91.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 2. It has decreased from 3.14 (Mar 23) to 0.95, marking a decrease of 2.19.
For PBDIT Margin (%), as of Mar 24, the value is 3.12. This value is below the healthy minimum of 10. It has decreased from 3.22 (Mar 23) to 3.12, marking a decrease of 0.10.
For PBIT Margin (%), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 2.01 (Mar 23) to 1.38, marking a decrease of 0.63.
For PBT Margin (%), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 10. It has decreased from 1.45 (Mar 23) to 1.01, marking a decrease of 0.44.
For Net Profit Margin (%), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 1.11 (Mar 23) to 0.71, marking a decrease of 0.40.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 8. It has decreased from 1.09 (Mar 23) to 0.53, marking a decrease of 0.56.
For Return on Networth / Equity (%), as of Mar 24, the value is 2.29. This value is below the healthy minimum of 15. It has decreased from 7.46 (Mar 23) to 2.29, marking a decrease of 5.17.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.57. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 23) to 5.57, marking a decrease of 6.88.
For Return On Assets (%), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 5. It has decreased from 5.33 (Mar 23) to 1.72, marking a decrease of 3.61.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.22, marking a decrease of 0.07.
For Asset Turnover Ratio (%), as of Mar 24, the value is 3.14. It has decreased from 4.48 (Mar 23) to 3.14, marking a decrease of 1.34.
For Current Ratio (X), as of Mar 24, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 23) to 3.48, marking an increase of 0.28.
For Quick Ratio (X), as of Mar 24, the value is 3.33. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 23) to 3.33, marking an increase of 0.22.
For Interest Coverage Ratio (X), as of Mar 24, the value is 8.50. This value is within the healthy range. It has increased from 5.81 (Mar 23) to 8.50, marking an increase of 2.69.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.94. This value is below the healthy minimum of 3. It has decreased from 3.00 (Mar 23) to 2.94, marking a decrease of 0.06.
For Enterprise Value (Cr.), as of Mar 24, the value is 399.87. It has decreased from 401.40 (Mar 23) to 399.87, marking a decrease of 1.53.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.94. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 1.94, marking an increase of 0.73.
For EV / EBITDA (X), as of Mar 24, the value is 62.10. This value exceeds the healthy maximum of 15. It has increased from 37.67 (Mar 23) to 62.10, marking an increase of 24.43.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
For Price / BV (X), as of Mar 24, the value is 8.29. This value exceeds the healthy maximum of 3. It has increased from 8.07 (Mar 23) to 8.29, marking an increase of 0.22.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 1.92, marking an increase of 0.74.
For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of A-1 Acid Ltd as of April 15, 2025 is: 146.87

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 15, 2025, A-1 Acid Ltd is Overvalued by 70.27% compared to the current share price 494.00

Intrinsic Value of A-1 Acid Ltd as of April 15, 2025 is: 154.87

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 15, 2025, A-1 Acid Ltd is Overvalued by 68.65% compared to the current share price 494.00

Last 5 Year EPS CAGR: 5.45%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (23.36 cr) compared to borrowings (15.55 cr), indicating strong financial stability. The company has shown consistent growth in sales (174.73 cr) and profit (3.91 cr) over the years.	The stock has a low average ROCE of 12.10%, which may not be favorable. The stock has a high average Working Capital Days of 67.50, which may not be favorable. The stock has a high average Cash Conversion Cycle of 70.10, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in A-1 Acid Ltd:
1. Net Profit Margin: 0.71%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.57% (Industry Average ROCE: 15.23%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 2.29% (Industry Average ROE: 10.7%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.94
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.33
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 160 (Industry average Stock P/E: 253.09)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.22
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

No data availabale for About the Company

INDUSTRY	ADDRESS	CONTACT
Industry not found	Address not found	Contact not found

Management Data not Available

FAQ

What is the intrinsic value of A-1 Acid Ltd?

A-1 Acid Ltd's intrinsic value (as of 14 April 2025) is ₹146.87 — 70.27% lower the current market price of 494.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 568 Cr. market cap, FY2025-2026 high/low of ₹535/290, reserves of 36 Cr, and liabilities of 75 Cr.

What is the Market Cap of A-1 Acid Ltd?

The Market Cap of A-1 Acid Ltd is 568 Cr..

What is the current Stock Price of A-1 Acid Ltd as on 14 April 2025?

The current stock price of A-1 Acid Ltd as on 14 April 2025 is 494.

What is the High / Low of A-1 Acid Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of A-1 Acid Ltd stocks is ₹535/290.

What is the Stock P/E of A-1 Acid Ltd?

The Stock P/E of A-1 Acid Ltd is 160.

What is the Book Value of A-1 Acid Ltd?

The Book Value of A-1 Acid Ltd is 41.6.

What is the Dividend Yield of A-1 Acid Ltd?

The Dividend Yield of A-1 Acid Ltd is 0.30 %.

What is the ROCE of A-1 Acid Ltd?

The ROCE of A-1 Acid Ltd is 4.67 %.

What is the ROE of A-1 Acid Ltd?

The ROE of A-1 Acid Ltd is 2.75 %.

What is the Face Value of A-1 Acid Ltd?

The Face Value of A-1 Acid Ltd is 10.0.